DrugPatentWatch Database Preview
Profile for United States of America Patent: 8148554
US Patent Family Members and Approved Drugs for United States of America Patent: 8148554
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Jun 16, 2019 | Eisai Inc | HALAVEN | eribulin mesylate |
➤ Sign Up | Jul 20, 2023 | Eisai Inc | HALAVEN | eribulin mesylate |
➤ Sign Up | Jun 16, 2019 | Eisai Inc | HALAVEN | eribulin mesylate |
➤ Sign Up | Jan 22, 2021 | Eisai Inc | HALAVEN | eribulin mesylate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |